BSE filing, NSE: PARMAX. Summary written from the filing by ALFA Finder's alert engine.
Parmax Pharma Ltd: key numbers
- Share price
- ₹133.70
- Market cap
- ₹50.02 Cr
- Revenue (annual)
- ₹12.11 Cr
- Net profit (annual)
- ₹-4.16 Cr
- P/E (TTM)
- -41.9×Sector 43.0×
- Promoter holding
- 64.66%+33.86% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Parmax Pharma Ltd
All →Parmax Pharma Management Change
Parmax Pharma's independent director Ami Shah resigned effective October 28, 2026. The exit follows a change in management and control of the company.
Parmax Pharma Other Announcement
Parmax Pharma Ltd filed its quarterly shareholding pattern for the quarter ended September 30, 2026, as required by SEBI regulations.
Parmax Pharma Management Change
Parmax Pharma Ltd announced the resignation of Mr. Nikhil Uchat as an Independent Director of the Company, effective October 08, 2026.
Parmax Pharma Annual General Meeting
Parmax Pharma Ltd conducted its 32nd Annual General Meeting on September 29, 2026, covering routine business including financial statement adoption and board appointments.
Parmax Pharma Adverse Business Impact
Parmax Pharma reported a major fire incident at its Rajkot plant on September 28, 2026. Two employees were injured, and the company is currently assessing the financial damage.
Parmax Pharma Other Announcement
Parmax Pharma Ltd filed its quarterly shareholding pattern under Regulation 31. The disclosure reflects changes in promoter status following a previously concluded open offer.
Other board meeting date announcements
All →Hasti Finance Board Meeting Date
Hasti Finance Limited will hold a board meeting on 14 November 2026 to consider unaudited financial results for the quarter and half year ended 30 September 2026. The trading window stays closed until 48 hours after the results are declared.
Neelam Linens And Garments (India) Board Meeting Date
Neelam Linens and Garments (India) Limited will hold a board meeting on 14 November 2026 to consider unaudited standalone half-yearly results for September 2026. The trading window stays closed until 16 November 2026.
Ultra Wiring Connectivity Systems Board Meeting Date
Ultra Wiring Connectivity will hold a board meeting on 14 Nov 2026 to consider unaudited half-yearly results. Trading window stays closed until 17 Nov 2026.
Roopa Industries Board Meeting Date
Roopa Industries Ltd intimated a board meeting on 14 Nov 2026 to consider unaudited half-year and quarterly results ended 30 Sep 2026. Trading window stays closed until 48 hours after results are made public.
Uravi Defence and Technology Board Meeting Date
Uravi Defence schedules a board meeting on 14 November 2026 to approve September quarter and half-year results. Trading window remains closed until 48 hours post-results.
Soma Textiles & Industries Board Meeting Date
Soma Textiles will hold a board meeting on 11 November 2026 to consider quarterly results for September 2026. The trading window remains closed until 13 November 2026.